search
Back to results

Banded Versus Conventional Laparoscopic Roux-en-Y (GABY) (GABY)

Primary Purpose

Morbid Obesity Requiring Bariatric Surgery

Status
Unknown status
Phase
Phase 4
Locations
International
Study Type
Interventional
Intervention
Conventional laparoscopic Roux-en-Y gastric bypass
conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring
Sponsored by
ClinTrio Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Morbid Obesity Requiring Bariatric Surgery focused on measuring bariatric, surgery, obesity, Roux-en-Y, gastric, medical device, bypass, adiposity, GaBP-Ring, BMI, banded, laparoscopic

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • BMI ≥ 40 kg /m2 to ≤ 50 kg/m2
  • Eating habit: sweet eater and volume eater
  • Signed informed consent
  • Patients with one or more of the following comorbidities: Hypertension, Diabetes mellitus Type 2, Hyperlipidemia, Hyperuricemia, Sleep apnea, Degenerative diseases of: Spine osteochondrosis, hip, knee, feet

Exclusion Criteria:

  • History of obesity surgery
  • History of major abdominal surgery with consecutive malabsorption (no resections of the stomach, small and large bowel (exception: appendectomy)
  • Patients not eligible to implement silastic ring size 6.5 cm
  • History of drug or alcohol abuse
  • History of major psychiatric illness conflicting with patient's compliance
  • History of recent or chronic steroid medication
  • Autoimmune disease
  • Inflammatory bowel disease or malabsorptive disease
  • Liver cirrhosis (CHILD B + C)
  • Active viral or bacterial disease (e.g. HIV, Hepatitis B or C, Tbc etc.)
  • Pregnant women or women with childbearing potential without efficient contraception
  • History of cancer in the last five years
  • Need of long-term anticoagulant medication for any reason
  • Any medication with ingredient ASA

Sites / Locations

  • Hospital Hallein (Scientific Review Board)
  • Hospital AZ St.-Jan AVRecruiting
  • AZ Sint-BlasiusRecruiting
  • AZ NikolaasRecruiting
  • Privatpraxis Chirurgie bei SchlossparkklinikRecruiting
  • Albert-Ludwigs-UniversityRecruiting
  • Universitätsklinikum Hamburg-Eppendorf (UKE)Recruiting
  • Chirurgische Klinik München-Bogenhausen GmbHRecruiting
  • Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbHRecruiting
  • Atruim Medical CentreRecruiting
  • Medical University of LodzRecruiting
  • Centro Hospitalar de Lisboa CentralRecruiting
  • Hospital de Sao SebastianoRecruiting
  • International Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Group A

Group B

Arm Description

Conventional laparoscopic Roux-en-Y gastric bypass (Golden Standard)

Conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring

Outcomes

Primary Outcome Measures

postoperative reduction of body mass index (BMI) and maintenance related to used bariatric procedure

Secondary Outcome Measures

Full Information

First Posted
November 17, 2009
Last Updated
February 16, 2011
Sponsor
ClinTrio Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT01015469
Brief Title
Banded Versus Conventional Laparoscopic Roux-en-Y (GABY)
Acronym
GABY
Official Title
International, Multi Centre, Open, Prospective, Randomized Study: Banded Versus Conventional Laparoscopic Roux-en-Y (GABY)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2011
Overall Recruitment Status
Unknown status
Study Start Date
February 2009 (undefined)
Primary Completion Date
March 2014 (Anticipated)
Study Completion Date
March 2015 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
ClinTrio Ltd.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Banded Versus Conventional Laparoscopic Roux-en-Y Gastric Bypass (GABY). The aim of this novel study is to evaluate, if an additional restrictive silastic ring can avoid dilation of the gastro-entero anastomosis and adjacent small bowel with consecutive better postoperative weight loss and significantly improved long-term weight maintenance. The study will not investigate the GaBP-Ring as medical product but the effect of the GaBP-Ring on weight loss in comparison to gastric bypass alone.
Detailed Description
GABY is designed as an international, multi center, open, prospective, randomized study to compare two methods of bariatric surgery: Banded versus conventional laparoscopic Roux-en-Y gastric bypass. At least 16 international high volume centres of excellence in bariatric surgery and at least 384 patients (24 patients at each center) in total will be included into this study. At least 320 patients must have completed the study after 5 years. Surgery will be performed according to standardized operating protocol. The group A (control group) will follow the worldwide golden standard of bariatric surgery (gastric bypass). Patients randomised to group B will receive in addition a restrictive silastic ring. The ring is a launched medical product and is registered in the European Community.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Morbid Obesity Requiring Bariatric Surgery
Keywords
bariatric, surgery, obesity, Roux-en-Y, gastric, medical device, bypass, adiposity, GaBP-Ring, BMI, banded, laparoscopic

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
384 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group A
Arm Type
Active Comparator
Arm Description
Conventional laparoscopic Roux-en-Y gastric bypass (Golden Standard)
Arm Title
Group B
Arm Type
Experimental
Arm Description
Conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring
Intervention Type
Procedure
Intervention Name(s)
Conventional laparoscopic Roux-en-Y gastric bypass
Intervention Description
Conventional laparoscopic Roux-en-Y gastric bypass
Intervention Type
Procedure
Intervention Name(s)
conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring
Intervention Description
conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring (GaBP-Ring)
Primary Outcome Measure Information:
Title
postoperative reduction of body mass index (BMI) and maintenance related to used bariatric procedure
Time Frame
0, 3, 6, 12 months and 2, 3, 4, 5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: BMI ≥ 40 kg /m2 to ≤ 50 kg/m2 Eating habit: sweet eater and volume eater Signed informed consent Patients with one or more of the following comorbidities: Hypertension, Diabetes mellitus Type 2, Hyperlipidemia, Hyperuricemia, Sleep apnea, Degenerative diseases of: Spine osteochondrosis, hip, knee, feet Exclusion Criteria: History of obesity surgery History of major abdominal surgery with consecutive malabsorption (no resections of the stomach, small and large bowel (exception: appendectomy) Patients not eligible to implement silastic ring size 6.5 cm History of drug or alcohol abuse History of major psychiatric illness conflicting with patient's compliance History of recent or chronic steroid medication Autoimmune disease Inflammatory bowel disease or malabsorptive disease Liver cirrhosis (CHILD B + C) Active viral or bacterial disease (e.g. HIV, Hepatitis B or C, Tbc etc.) Pregnant women or women with childbearing potential without efficient contraception History of cancer in the last five years Need of long-term anticoagulant medication for any reason Any medication with ingredient ASA
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Burkhart Frankenberger
Phone
+49-511-38814-0
Email
info@clintrio.com
First Name & Middle Initial & Last Name or Official Title & Degree
Maria Noraman
Phone
+49-511-38814-0
Email
m.noraman@clintrio.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Konrad W Karcz, MD
Organizational Affiliation
Albert-Ludwigs-University of Freiburg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Hallein (Scientific Review Board)
City
Hallein
ZIP/Postal Code
5400
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Hospital AZ St.-Jan AV
City
Brugge
ZIP/Postal Code
8000
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bruno Dillemans, MD
Facility Name
AZ Sint-Blasius
City
Dendermonde
ZIP/Postal Code
9200
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jaques Himpens, MD
Facility Name
AZ Nikolaas
City
Sint-Niklaas
ZIP/Postal Code
9100
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luc Lemmens, MD
Facility Name
Privatpraxis Chirurgie bei Schlossparkklinik
City
Berlin
ZIP/Postal Code
14059
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Volker Lange, Prof.
Facility Name
Albert-Ludwigs-University
City
Freiburg
ZIP/Postal Code
79106
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Konrad W Karcz, MD
Facility Name
Universitätsklinikum Hamburg-Eppendorf (UKE)
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Oliver Mann, MD
Facility Name
Chirurgische Klinik München-Bogenhausen GmbH
City
München
ZIP/Postal Code
81679
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Günther Meyer, MD
Facility Name
Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH
City
Villingen-Schwenningen
ZIP/Postal Code
78011
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Norbert Runkel, Prof.
Facility Name
Atruim Medical Centre
City
Heerlen
ZIP/Postal Code
6401
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jan W.M. Greve, MD
Facility Name
Medical University of Lodz
City
Lodz
ZIP/Postal Code
90-152
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tomasz Szewczyk, MD
Facility Name
Centro Hospitalar de Lisboa Central
City
Lisboa
ZIP/Postal Code
1150-199
Country
Portugal
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rui Ribeiro, MD
Facility Name
Hospital de Sao Sebastiano
City
Santa Maria de Feira
ZIP/Postal Code
4520-211
Country
Portugal
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mario Nora, MD
Facility Name
International Medical Center
City
Jeddah
ZIP/Postal Code
2172
Country
Saudi Arabia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Walid Bukhari, MD

12. IPD Sharing Statement

Learn more about this trial

Banded Versus Conventional Laparoscopic Roux-en-Y (GABY)

We'll reach out to this number within 24 hrs